Gainers
- Agape ATP ATPC shares rose 92.1% to $0.98 during Tuesday's pre-market session. The company's market cap stands at $75.5 million.
- Jin Medical International ZJYL stock moved upwards by 63.67% to $299.5. The company's market cap stands at $2.3 billion.
- Iterum Therapeutics ITRM stock increased by 60.89% to $2.88. The market value of their outstanding shares is at $38.6 million.
- Motus GI Hldgs MOTS stock rose 56.93% to $1.5. The market value of their outstanding shares is at $2.3 million.
- Precision BioSciences DTIL stock moved upwards by 16.88% to $0.45. The company's market cap stands at $54.8 million.
- Cidara Therapeutics CDTX stock rose 15.89% to $0.78. The company's market cap stands at $70.5 million.
Losers
- 60 Degrees SXTP stock fell 30.9% to $0.36 during Tuesday's pre-market session. The company's market cap stands at $2.0 million.
- CNS Pharma CNSP shares declined by 21.64% to $0.26. The market value of their outstanding shares is at $1.6 million.
- OneMedNet ONMD stock declined by 21.17% to $1.08. The company's market cap stands at $34.8 million.
- Addex Therapeutics ADXN stock decreased by 16.04% to $11.0. The company's market cap stands at $12.3 million.
- Calidi Biotherapeutics CLDI shares decreased by 11.12% to $0.8. The market value of their outstanding shares is at $28.3 million.
- Acutus Medical AFIB stock decreased by 10.41% to $0.22. The market value of their outstanding shares is at $6.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AFIBAcutus Medical Inc
$0.0600-33.3%
ATPCAgape ATP Corp
$1.5126.9%
CDTXCidara Therapeutics Inc
$23.996.57%
CLDICalidi Biotherapeutics Inc
$1.35-6.90%
CNSPCNS Pharmaceuticals Inc
$0.11131.18%
DTILPrecision BioSciences Inc
$4.702.17%
ITRMIterum Therapeutics PLC
$1.771.15%
MOTSMotus GI Holdings Inc
--%
ONMDOneMedNet Corp
$1.4336.2%
SXTP60 Degrees Pharmaceuticals Inc
$1.26-10.6%
ZJYLJin Medical International Ltd
$0.86001.19%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in